Listed

Acadia Pharmaceuticals Inc

ACADNasdaqCIK 1070494HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$308.0m, Q2 FY2026
Operating income$37.8m, Q2 FY2026
Net income$31.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m212Revenue, Q3 FY2023, three months to 2023-09-30$211.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure231Revenue, Q4 FY2023, three months to 2023-12-31$231.0m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-28, accession 0000950170-24-021473.Report this figure206Revenue, Q1 FY2024, three months to 2024-03-31$205.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure242Revenue, Q2 FY2024, three months to 2024-06-30$242.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure250Revenue, Q3 FY2024, three months to 2024-09-30$250.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure260Revenue, Q4 FY2024, three months to 2024-12-31$259.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure244Revenue, Q1 FY2025, three months to 2025-03-31$244.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure265Revenue, Q2 FY2025, three months to 2025-06-30$264.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure279Revenue, Q3 FY2025, three months to 2025-09-30$278.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure284Revenue, Q4 FY2025, three months to 2025-12-31$284.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure268Revenue, Q1 FY2026, three months to 2026-03-31$268.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure308Revenue, Q2 FY2026, three months to 2026-06-30$308.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Cost of revenue$m14.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$14.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure17.9Cost of revenue, Q4 FY2023, three months to 2023-12-31$17.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure23.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$23.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure18.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$18.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure18.9Cost of revenue, Q3 FY2024, three months to 2024-09-30$18.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure21.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$21.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure20.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$20.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure20.7Cost of revenue, Q2 FY2025, three months to 2025-06-30$20.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure21.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$21.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure26.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$26.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure24.8Cost of revenue, Q1 FY2026, three months to 2026-03-31$24.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure28.3Cost of revenue, Q2 FY2026, three months to 2026-06-30$28.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Gross profit$m197Gross profit, Q3 FY2023, three months to 2023-09-30$197.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-28, accession 0000950170-24-021473.Report this figure213Gross profit, Q4 FY2023, three months to 2023-12-31$213.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-28, accession 0000950170-24-021473.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m157Research and development, Q3 FY2023, three months to 2023-09-30$157.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure66.7Research and development, Q4 FY2023, three months to 2023-12-31$66.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure59.7Research and development, Q1 FY2024, three months to 2024-03-31$59.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure76.2Research and development, Q2 FY2024, three months to 2024-06-30$76.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure66.6Research and development, Q3 FY2024, three months to 2024-09-30$66.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure101Research and development, Q4 FY2024, three months to 2024-12-31$100.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure78.3Research and development, Q1 FY2025, three months to 2025-03-31$78.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure78.0Research and development, Q2 FY2025, three months to 2025-06-30$78.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure87.8Research and development, Q3 FY2025, three months to 2025-09-30$87.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure84.8Research and development, Q4 FY2025, three months to 2025-12-31$84.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure76.9Research and development, Q1 FY2026, three months to 2026-03-31$76.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure81.6Research and development, Q2 FY2026, three months to 2026-06-30$81.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Selling, general and administrative$m97.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$97.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure111Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$111.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure108Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$108.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure117Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$117.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure133Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$133.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure130Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$130.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure126Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$126.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure134Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$133.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure133Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$133.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure156Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$155.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure171Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$171.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure160Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$160.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Operating income$m(57.8)Operating income, Q3 FY2023, three months to 2023-09-30−$57.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure34.9Operating income, Q4 FY2023, three months to 2023-12-31$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure15.2Operating income, Q1 FY2024, three months to 2024-03-31$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure30.4Operating income, Q2 FY2024, three months to 2024-06-30$30.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure31.6Operating income, Q3 FY2024, three months to 2024-09-30$31.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure154Operating income, Q4 FY2024, three months to 2024-12-31$153.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure19.3Operating income, Q1 FY2025, three months to 2025-03-31$19.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure32.4Operating income, Q2 FY2025, three months to 2025-06-30$32.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure35.8Operating income, Q3 FY2025, three months to 2025-09-30$35.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure17.4Operating income, Q4 FY2025, three months to 2025-12-31$17.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure(4.6)Operating income, Q1 FY2026, three months to 2026-03-31−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure37.8Operating income, Q2 FY2026, three months to 2026-06-30$37.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Income tax$m13.0Income tax, Q3 FY2023, three months to 2023-09-30$13.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure(6.1)Income tax, Q4 FY2023, three months to 2023-12-31−$6.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure4.4Income tax, Q1 FY2024, three months to 2024-03-31$4.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure3.8Income tax, Q2 FY2024, three months to 2024-06-30$3.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure6.0Income tax, Q3 FY2024, three months to 2024-09-30$6.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure17.3Income tax, Q4 FY2024, three months to 2024-12-31$17.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure8.8Income tax, Q1 FY2025, three months to 2025-03-31$8.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure13.5Income tax, Q2 FY2025, three months to 2025-06-30$13.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure(27.2)Income tax, Q3 FY2025, three months to 2025-09-30−$27.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure(247)Income tax, Q4 FY2025, three months to 2025-12-31−$247.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2026, three months to 2026-03-31$344.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure15.0Income tax, Q2 FY2026, three months to 2026-06-30$15.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Net income$m(65.2)Net income, Q3 FY2023, three months to 2023-09-30−$65.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure45.8Net income, Q4 FY2023, three months to 2023-12-31$45.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-28, accession 0000950170-24-021473.Report this figure16.6Net income, Q1 FY2024, three months to 2024-03-31$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure33.4Net income, Q2 FY2024, three months to 2024-06-30$33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure32.8Net income, Q3 FY2024, three months to 2024-09-30$32.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure144Net income, Q4 FY2024, three months to 2024-12-31$143.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure19.0Net income, Q1 FY2025, three months to 2025-03-31$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure26.7Net income, Q2 FY2025, three months to 2025-06-30$26.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure71.8Net income, Q3 FY2025, three months to 2025-09-30$71.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure274Net income, Q4 FY2025, three months to 2025-12-31$273.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure3.6Net income, Q1 FY2026, three months to 2026-03-31$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure31.5Net income, Q2 FY2026, three months to 2026-06-30$31.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Diluted EPS$ per share(0.40)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure0.28Diluted EPS, Q4 FY2023, three months to 2023-12-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-28, accession 0000950170-24-021473.Report this figure0.10Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure0.20Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure0.20Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figurenot reported0.11Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure0.16Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure0.42Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figurenot reported0.02Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure0.18Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Basic EPS$ per share(0.40)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure0.28Basic EPS, Q4 FY2023, three months to 2023-12-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-02-28, accession 0000950170-24-021473.Report this figure0.10Basic EPS, Q1 FY2024, three months to 2024-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure0.20Basic EPS, Q2 FY2024, three months to 2024-06-30$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure0.20Basic EPS, Q3 FY2024, three months to 2024-09-30$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figurenot reported0.11Basic EPS, Q1 FY2025, three months to 2025-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure0.16Basic EPS, Q2 FY2025, three months to 2025-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure0.43Basic EPS, Q3 FY2025, three months to 2025-09-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figurenot reported0.02Basic EPS, Q1 FY2026, three months to 2026-03-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure0.18Basic EPS, Q2 FY2026, three months to 2026-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure

Balance sheet

Cash and equivalents$385.0m, Q2 FY2026
Shareholders' equity$1.31bn, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m98.2Cash and equivalents, Q3 FY2023, at 2023-09-30$98.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure189Cash and equivalents, FY2023, at 2023-12-31$188.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-072519.Report this figure205Cash and equivalents, Q1 FY2024, at 2024-03-31$204.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure177Cash and equivalents, Q2 FY2024, at 2024-06-30$177.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure155Cash and equivalents, Q3 FY2024, at 2024-09-30$155.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure320Cash and equivalents, FY2024, at 2024-12-31$319.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure218Cash and equivalents, Q1 FY2025, at 2025-03-31$217.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure254Cash and equivalents, Q2 FY2025, at 2025-06-30$253.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure258Cash and equivalents, Q3 FY2025, at 2025-09-30$258.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure178Cash and equivalents, FY2025, at 2025-12-31$177.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure282Cash and equivalents, Q1 FY2026, at 2026-03-31$282.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure385Cash and equivalents, Q2 FY2026, at 2026-06-30$385.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Current assets$m499Current assets, Q3 FY2023, at 2023-09-30$499.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0000950170-23-058436.Report this figure616Current assets, FY2023, at 2023-12-31$616.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029253.Report this figure675Current assets, Q1 FY2024, at 2024-03-31$675.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056077.Report this figure729Current assets, Q2 FY2024, at 2024-06-30$728.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092163.Report this figure788Current assets, Q3 FY2024, at 2024-09-30$788.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure938Current assets, FY2024, at 2024-12-31$938.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-072519.Report this figure871Current assets, Q1 FY2025, at 2025-03-31$870.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure961Current assets, Q2 FY2025, at 2025-06-30$960.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure1,076Current assets, Q3 FY2025, at 2025-09-30$1.08bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure1,062Current assets, FY2025, at 2025-12-31$1.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure1,096Current assets, Q1 FY2026, at 2026-03-31$1.10bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure1,225Current assets, Q2 FY2026, at 2026-06-30$1.22bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Total assets$m633Total assets, Q3 FY2023, at 2023-09-30$632.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0000950170-23-058436.Report this figure749Total assets, FY2023, at 2023-12-31$749.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029253.Report this figure855Total assets, Q1 FY2024, at 2024-03-31$855.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056077.Report this figure914Total assets, Q2 FY2024, at 2024-06-30$914.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092163.Report this figure977Total assets, Q3 FY2024, at 2024-09-30$976.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure1,188Total assets, FY2024, at 2024-12-31$1.19bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-072519.Report this figure1,132Total assets, Q1 FY2025, at 2025-03-31$1.13bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure1,226Total assets, Q2 FY2025, at 2025-06-30$1.23bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure1,331Total assets, Q3 FY2025, at 2025-09-30$1.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure1,564Total assets, FY2025, at 2025-12-31$1.56bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure1,605Total assets, Q1 FY2026, at 2026-03-31$1.61bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure1,743Total assets, Q2 FY2026, at 2026-06-30$1.74bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Current liabilities$m210Current liabilities, Q3 FY2023, at 2023-09-30$209.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0000950170-23-058436.Report this figure254Current liabilities, FY2023, at 2023-12-31$254.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029253.Report this figure331Current liabilities, Q1 FY2024, at 2024-03-31$330.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056077.Report this figure338Current liabilities, Q2 FY2024, at 2024-06-30$337.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092163.Report this figure344Current liabilities, Q3 FY2024, at 2024-09-30$343.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure395Current liabilities, FY2024, at 2024-12-31$394.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-072519.Report this figure303Current liabilities, Q1 FY2025, at 2025-03-31$302.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure330Current liabilities, Q2 FY2025, at 2025-06-30$330.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure357Current liabilities, Q3 FY2025, at 2025-09-30$356.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure277Current liabilities, FY2025, at 2025-12-31$277.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure306Current liabilities, Q1 FY2026, at 2026-03-31$305.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure361Current liabilities, Q2 FY2026, at 2026-06-30$361.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Total liabilities$m270Total liabilities, Q3 FY2023, at 2023-09-30$270.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0000950170-23-058436.Report this figure317Total liabilities, FY2023, at 2023-12-31$317.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029253.Report this figure391Total liabilities, Q1 FY2024, at 2024-03-31$391.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056077.Report this figure397Total liabilities, Q2 FY2024, at 2024-06-30$397.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092163.Report this figure400Total liabilities, Q3 FY2024, at 2024-09-30$399.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure455Total liabilities, FY2024, at 2024-12-31$455.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-072519.Report this figure367Total liabilities, Q1 FY2025, at 2025-03-31$367.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure403Total liabilities, Q2 FY2025, at 2025-06-30$403.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure413Total liabilities, Q3 FY2025, at 2025-09-30$413.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure337Total liabilities, FY2025, at 2025-12-31$336.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure357Total liabilities, Q1 FY2026, at 2026-03-31$357.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure436Total liabilities, Q2 FY2026, at 2026-06-30$436.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m362Shareholders' equity, Q3 FY2023, at 2023-09-30$362.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure432Shareholders' equity, FY2023, at 2023-12-31$431.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-072519.Report this figure464Shareholders' equity, Q1 FY2024, at 2024-03-31$464.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure517Shareholders' equity, Q2 FY2024, at 2024-06-30$516.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure577Shareholders' equity, Q3 FY2024, at 2024-09-30$577.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure733Shareholders' equity, FY2024, at 2024-12-31$732.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure765Shareholders' equity, Q1 FY2025, at 2025-03-31$765.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure822Shareholders' equity, Q2 FY2025, at 2025-06-30$822.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure917Shareholders' equity, Q3 FY2025, at 2025-09-30$917.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure1,227Shareholders' equity, FY2025, at 2025-12-31$1.23bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure1,248Shareholders' equity, Q1 FY2026, at 2026-03-31$1.25bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure1,307Shareholders' equity, Q2 FY2026, at 2026-06-30$1.31bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure

Cash flow

Operating cash flow$100.8m, Q2 FY2026
Capital expenditure$5.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(59.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$59.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122513. Derived: 9-month figure less the 6-month figure.Report this figure85.4Operating cash flow, Q4 FY2023, three months to 2023-12-31$85.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure29.1Operating cash flow, Q1 FY2024, three months to 2024-03-31$29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure25.0Operating cash flow, Q2 FY2024, three months to 2024-06-30$25.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104295. Derived: 6-month figure less the 3-month figure.Report this figure63.2Operating cash flow, Q3 FY2024, three months to 2024-09-30$63.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-267453. Derived: 9-month figure less the 6-month figure.Report this figure40.4Operating cash flow, Q4 FY2024, three months to 2024-12-31$40.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure20.3Operating cash flow, Q1 FY2025, three months to 2025-03-31$20.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure64.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$64.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333243. Derived: 6-month figure less the 3-month figure.Report this figure74.3Operating cash flow, Q3 FY2025, three months to 2025-09-30$74.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-267453. Derived: 9-month figure less the 6-month figure.Report this figure(48.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$48.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure34.0Operating cash flow, Q1 FY2026, three months to 2026-03-31$34.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure101Operating cash flow, Q2 FY2026, three months to 2026-06-30$100.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333243. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reported0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$70.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-267453. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$453.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure0.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$297.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-333243. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$388.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-267453. Derived: 9-month figure less the 6-month figure.Report this figure4.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-072519. Derived: 12-month figure less the 9-month figure.Report this figure5.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure5.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-333243. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)172.85m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30161,852 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0000950170-23-058436.Report this figure162Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31162,263,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056077.Report this figure165Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30165,046,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092163.Report this figure164Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30164,234,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122513.Report this figure167Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31166,623,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066231.Report this figure166Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30166,174,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104295.Report this figure166Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30166,178,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure168Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31167,668,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure169Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30168,681,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure171Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30170,650,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-267453.Report this figure173Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31172,706,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-209731.Report this figure173Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30172,851,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure

Shares outstanding: 172.31mShares outstanding, period not labelled, at 2026-07-28172,305,518 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333243.Report this figure at Jul 28, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.